This comprehensive resource covers a range of women’s health issues and their intersection with neurologic and psychiatric disease. Chapters feature high quality, integrated information based on leading-edge research on gender-specific care and are grouped by reproductive years, pregnancy and health, and aging. Emerging science regarding sex differences in neurological and psychiatric illnesses, including anxiety, reproductive health, conversion disorders, depression and ethical issues in pregnancy, stroke risk factors, and successful aging strategies are covered along with clinical application of this knowledge to the delivery of care. In addition, in those medical problems that afflict both men and women, authors will point out the different risks, prevalence, presentations, and responses to treatments or outcomes in women. Written by renowned experts in the field, this textbook will thoroughly address the educational needs of physicians, nurse practitioners, and physician assistants in the areas of neurology, psychiatry, internal medicine, and obstetrics and expanding their understanding of concerns unique to female patients.

Sex Differences in Neurology and Psychiatry, Volume 175, addresses this important issue by viewing major neurological and psychiatric conditions through the lens of sexual dimorphism, providing an entirely novel approach to understanding vulnerability factors, as well as potential new treatment strategies in several common neuropsychiatric disorders. The handbook comprises four major sections: (1) Introduction to sex differences in neuroanatomy and neurophysiology, (2) Description of the impact of genetic, epigenetic, sex hormonal and other environmental effects on cerebral sex dimorphism, (3) Review of sex differences in neurologic disorders, and (4) Review of sex differences in psychiatric disorders. - Explores sex differences in human neuroanatomy and neurophysiology - Offers a pathway toward a gender-specific treatment of neurologic and psychiatric disorders - Provides an overview of the genetics of sex hormones, human brain structure, and function, as well as the epigenetics, environment and social context

The Oxford Textbook of Women and Mental Health brings a balanced understanding of different aspects of gender and mental health. Exploring issues covering psychological, social, and cultural aspects of mental health problems, it looks at epidemiological data that shows increased frequency in different clinical aspects of many psychiatric disorders, the biological and endocrinological concomitants of mental health, and eating disorders, perinatal psychiatric disorders, and the long term effects of abuse - helping readers to appreciate the societal, parental, and personal consequences of mental health problems. Part one is dedicated to fundamental aspects in women's mental health. It covers topics from women's health as a global issue to different medical psychological theories, giving an overview of gender in mental health. The second examines clinical aspects of women and mental health. In part three, special clinical topics such as PTSD, self-harm, menopause, violence and its management are investigated. Part four focuses on parental psychiatric disorders, clarifying how mental health and behavioural problems in children can be a marker or consequence of maternal distress. The final two parts look at the topics of women and disability, and legislation and policy. A book of exceptional scope and depth, it will be essential for all those health professionals involved in managing mental health problems in women

Apathy is characterized by loss of motivation, decreased initiative, and emotional blunting. It is highly prevalent in neurological, and psychiatric disorders like Alzheimer's disease, traumatic brain injury, schizophrenia, Parkinson's disease, Huntington's disease, cerebrovascular disorders, and mild behavioural impairment. It has negative outcomes including impairments in activities of daily living, caregiver burden, and higher rates of institutionalization and mortality. The definition of apathy has changed over the years alongside the development of diagnostic criteria and apathy scales and measurements. Apathy is emerging as a treatment target with interest in pharmacological, non-pharmacological, and neuromodulatory treatments for apathy. There is also an increased understanding of the neurobiology of apathy with functional and structural neuroimaging research studies. This book is a comprehensive, in-depth review from experts in neurology and psychiatry. It reviews the current state of apathy in these various disorders while also summarizing apathy diagnostic criteria, scales and measurements, neuropathology, and treatments.

Although there appears to be a general understanding that the human brain functions similarly in women and in men, an increasing body of knowledge indicates that neuronal connectivity, recruitment, and disease patterns exhibit gender differences. There are clear gender differences in genetic expression, physiologic function, metabolism, hormonal makeup, and psychosocial profile, which often modify the clinical expression of neurologic and other diseases. In addition, ethnic, cultural, and economic factors are frequently overlooked in dealing with health problems of women, even though they undoubtedly have a strong influence on the clinical course of the illness. The second edition of Neurologic Disease in Women, the only text to specifically cover this important topic, will help physicians and other medical personnel seeking information relevant to clinical care. Sections address general anatomic, hormonal, epidemiologic, and drug aspects of women's health; neurologic conditions that arise during childhood, pregnancy, adulthood, and old age in females; and particular neurologic conditions that present differently or predominantly in females. There have been important advances in several areas prompting new chapters, new approaches and additional information provided in chapters on hormonal effects in women and the use of HRT; the adverse effects of antiepileptic drugs on hormonal homeostasis, weight and bone health; and cardiovascular diseases in women. New chapters include ones on reproductive and metabolic disorders with AED use, and on movement disorders.

Big Data in Psychiatry and Neurology provides an up-to-date overview of achievements in the field of big data in Psychiatry and Medicine, including applications of big data methods to aging disorders (e.g., Alzheimer's disease and Parkinson's disease), mood disorders (e.g., major depressive disorder), and drug addiction. This book will help researchers, students and clinicians implement new methods for collecting big datasets from various patient populations. Further, it will demonstrate how to use several algorithms and machine learning methods to analyze big datasets, thus providing individualized treatment for psychiatric and neurological patients. As big data analytics is gaining traction in psychiatric research, it is an essential component in providing predictive models for both clinical practice and public health systems. As compared with traditional statistical methods that provide primarily average group-level results, big data analytics allows predictions and stratification of clinical outcomes at an individual subject level. - Discusses longitudinal big data and risk factors surrounding the development of psychiatric disorders - Analyzes methods in using big data to treat psychiatric and neurological disorders - Describes the role machine learning can play in the analysis of big data - Demonstrates the various methods of gathering big data in medicine - Reviews how to apply big data to genetics

This book reviews key recent advances and new frontiers within psychiatric research and clinical practice. These advances either represent or are enabling paradigm shifts in the discipline and are influencing how we observe, derive and test hypotheses, and intervene. Progress in information technology is allowing the collection of scattered, fragmented data and the discovery of hidden meanings from stored data, and the impacts on psychiatry are fully explored. Detailed attention is also paid to the applications of artificial intelligence, machine learning, and data science technology in psychiatry and to their role in the development of new hypotheses, which in turn promise to lead to new discoveries and treatments. Emerging research methods for precision medicine are discussed, as are a variety of novel theoretical frameworks for research, such as theoretical psychiatry, the developmental approach to the definition of psychopathology, and the theory of constructed emotion. The concluding section considers novel interventions and treatment avenues, including psychobiotics, the use of neuromodulation to augment cognitive control of emotion, and the role of the telomere-telomerase system in psychopharmacological interventions.